-- Results to date demonstrate rapid post-surgical visual recovery with no serious adverse events and meet or exceed FDA target rates for safety and effectiveness – -- Data presented today at Eyecelerator meeting in Park City -- CAMBRIDGE, Mass., May 2, 2025 /PRNewswire/ -- Pykus...
Read More Details
Finally We wish PressBee provided you with enough information of ( Pykus Therapeutics Announces Positive Interim Pilot Clinical Trial Results of PYK-2101, a Novel Retinal Sealant )
Also on site :
- Michael J. Fox Fans Send Love After Rare Appearance Using Wheelchair
- James B. Milliken, University of Texas chancellor, named University of California president
- PHOTO GALLERY:Europe-US-V-E-Day